Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Universe Pharmaceuticals Inc. | StockGist | StockGist

Companies
UPC
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings UPCSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Universe Pharmaceuticals Inc.

Filed Feb 14, 2025

Accepted Feb 13, 2025, 7:00 PM ET

CIK 0001809616

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

% of Class

9.90%

Reporting Person

Universe Pharmaceuticals INC

Person Type

IA

Amendment History

3 filings

SCHEDULE 13G
Original
Viewing
Feb 14, 20250000950170-25-021487
SCHEDULE 13G/A
Amendment 1
May 15, 20250000950170-25-072930
SCHEDULE 13G/A
Amendment 2
Latest
Jan 7, 20260001535610-26-000006

Key Facts

% of Class

9.90%

Recent Filings

Universe Pharmaceuticals Inc.1 months ago

Universe Pharmaceuticals Inc.2 months ago

Universe Pharmaceuticals Inc.2 months ago

Universe Pharmaceuticals Inc.7 months ago

Universe Pharmaceuticals Inc.7 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice